Polygenic Risk Stratification Combined With mpMRI to Identify Clinically Relevant Prostate Cancer

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(5 sites)

United States

Howard University Hospital, Washington D.C., District of Columbia

National Cancer Institute, Bethesda, Maryland

Walter Reed National Military Medical Center, Bethesda, Maryland

Massachusetts General Hospital, Boston, Massachusetts

Brigham and Women's Hospital, Boston, Massachusetts